INIS
patients
100%
levels
50%
valves
50%
risks
50%
sex
50%
biological markers
50%
prediction
50%
validation
25%
tissues
25%
females
25%
blood
25%
males
25%
brain
25%
monitoring
25%
inflammation
25%
proteins
25%
medicine
25%
statistics
25%
interactions
25%
atherosclerosis
25%
peptides
25%
esterases
25%
Keyphrases
Atrial Fibrillation Progression
100%
Paroxysmal Atrial Fibrillation
100%
Paroxysmal AF
40%
Atrial Fibrillation
20%
Multivariable
20%
Waist Circumference
20%
Persistent Atrial Fibrillation
20%
Mitral Valve Regurgitation
20%
Prediction Model
10%
Inflammation
10%
Personalized Medicine
10%
C-statistic
10%
Blood Biomarkers
10%
Electrical Remodeling
10%
Atrial Remodeling
10%
Atrial Fibrillation Treatment
10%
Hypercoagulability
10%
Cardiomyocytes
10%
Male Sex
10%
Risk Prediction Model
10%
C1 Esterase Inhibitor
10%
Coagulation
10%
Interim Analysis
10%
Tissue Factor Pathway inhibitor-2 (TFPI-2)
10%
Targeted Treatment
10%
PR Interval
10%
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9)
10%
Left Atrial Function
10%
Inhibitor Factor
10%
Factor XIIa
10%
Continuous Rhythm Monitoring
10%
Permanent Form
10%
Peptidoglycan Recognition Protein 1
10%
Familial Atrial Fibrillation
10%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
10%
Risk of Progression
10%
Medicine and Dentistry
Prevalence
100%
Atrial Fibrillation
100%
Paroxysmal Atrial Fibrillation
100%
Biological Marker
16%
Mitral Insufficiency
16%
Tissue Factor Pathway Inhibitor
8%
Atherosclerosis
8%
Brain Natriuretic Peptide
8%
Cardiac Muscle Cell
8%
Amino Terminal Sequence
8%
Hypercoagulability
8%
Rhythm
8%
Personalized Medicine
8%
Synapsin I
8%
Interim Analysis
8%
Complement Component C1s Inhibitor
8%
Proprotein Convertase 9
8%
Persistent Atrial Fibrillation
8%
Heart Atrium Remodeling
8%
Permanent Atrial Fibrillation
8%
PR Interval
8%
Heart Atrium Function
8%
Vascular Destabilization
8%
Peptidoglycan Recognition Protein
8%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Atrial Fibrillation
100%
Paroxysmal Atrial Fibrillation
100%
Biological Marker
16%
Mitral Valve Regurgitation
16%
Inflammation
8%
Tissue Factor Pathway Inhibitor
8%
Atherosclerosis
8%
Brain Natriuretic Peptide
8%
Synapsin I
8%
Proprotein Convertase 9
8%
Hypercoagulability
8%
Heart Atrium Remodeling
8%
Permanent Atrial Fibrillation
8%
Persistent Atrial Fibrillation
8%
Complement Component C1s Inhibitor
8%
Peptidoglycan Recognition Protein
8%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Atrial Fibrillation
100%
Waist Circumference
13%
N-Terminus
6%
Synapsin I
6%
Cardiac Muscle Cell
6%
Kexin
6%
Subtilisin
6%
Proprotein Convertase
6%
Rhythm
6%
C1-Inhibitor
6%
Tissue Factor Pathway Inhibitor
6%
PR Interval
6%
Heart Atrium Function
6%
Brain Natriuretic Peptide
6%
Peptidoglycan
6%